These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12707221)

  • 1. Clinical consequences of iron overload in hemochromatosis homozygotes.
    Ajioka RS; Kushner JP
    Blood; 2003 May; 101(9):3351-3; discussion 3354-8. PubMed ID: 12707221
    [No Abstract]   [Full Text] [Related]  

  • 2. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis.
    Beutler E
    Blood; 2003 May; 101(9):3347-50. PubMed ID: 12707220
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening.
    Gleeson F; Ryan E; Barrett S; Crowe J
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical penetrance of hereditary hemochromatosis.
    Bacon BR; Britton RS
    N Engl J Med; 2008 Jan; 358(3):291-2. PubMed ID: 18199868
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
    Adams PC; Reboussin DM; Leiendecker-Foster C; Moses GC; McLaren GD; McLaren CE; Dawkins FW; Kasvosve I; Acton RT; Barton JC; Zaccaro D; Harris EL; Press R; Chang H; Eckfeldt JH
    Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for iron overload and HFE mutations in a university hospital.
    Remacha AF; Carrasco M; Sardà MP; Barceló MJ; Blesa I; Baiget M
    Haematologica; 2000 Aug; 85(8):873-4. PubMed ID: 10942939
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemochromatosis mutations in the general population: iron overload progression rate.
    Andersen RV; Tybjaerg-Hansen A; Appleyard M; Birgens H; Nordestgaard BG
    Blood; 2004 Apr; 103(8):2914-9. PubMed ID: 15070663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
    Barton JC; Barton EH; Acton RT
    BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection and HFE hemochromatosis.
    Beutler E; Gelbart T
    Blood Cells Mol Dis; 2006; 37(3):188-91. PubMed ID: 16996754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is HFE haemochromatosis?
    Marjot T; Collier J; Ryan JD
    Br J Hosp Med (Lond); 2016 Jun; 77(6):C91-5. PubMed ID: 27269766
    [No Abstract]   [Full Text] [Related]  

  • 19. Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis.
    Rees DC; Singh BM; Luo LY; Wickramasinghe S; Thein SL
    Ann N Y Acad Sci; 1998 Jun; 850():490-4. PubMed ID: 9668593
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for hemochromatosis.
    Asberg A; Thorstensen K; Irgens W; Hveem K
    Blood; 2008 Apr; 111(7):3896; author reply 3897. PubMed ID: 18362213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.